New Perspectives on Zoledronic Acid in Breast Cancer: Potential Augmentation of Anticancer Immune Response

Author： Hamilton Erika Clay Timothy M. Blackwell Kimberly L.

ISSN： 0735-7907

Source： Cancer Investigation, Vol.29, Iss.8, 2011-09, pp. : 533-541

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance

By Zhao Xinmin

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 733-743

Springer Publishing Company

Access to resources Recommend Favorite

Anticancer Properties of Zoledronic Acid

By Green Jonathan Lipton Allan

Cancer Investigation, Vol. 28, Iss. 9, 2010-10 ,pp. : 944-957

Informa Healthcare

Access to resources Recommend Favorite

Pain Control with Zoledronic Acid in Patients with Breast Cancer and Metastatic Bone Disease

By Cinzia Nigro Michela Donadio Mara Ardine Alessandra Beano Marinella Mistrangelo Zaira Coccorullo Oscar Bertetto

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 257-263

Adis International

Access to resources Recommend Favorite

Jaw complications in breast and prostate cancer patients treated with zoledronic acid

By Ortega C. Faggiuolo R. Vormola R. Montemurro F. Nanni D. Goia F. Aglietta M.

Acta Oncologica, Vol. 45, Iss. 2, 2006-03 ,pp. : 216-217

Informa Healthcare

Access to resources Recommend Favorite

Relevance of Micrometastases and Targeting the Bone Marrow Niche with Zoledronic Acid in Breast Cancer

Current Cancer Therapy Reviews, Vol. 8, Iss. 2, 2012-05 ,pp. : 152-160

Bentham Science Publishers

Access to resources Recommend Favorite